Breaking News: Sanofi acquires Cambridge biotech for $9.1 billion
The French pharmaceutical giant is acquiring a Cambridge biotech and its rare immunology disease which is already approved in the U.S. and European Union.
The French pharmaceutical giant is acquiring a Cambridge biotech and its rare immunology disease which is already approved in the U.S. and European Union.
ليست هناك تعليقات:
إرسال تعليق